Resultados de búsqueda - Morris Edelman

Ruxolitinib and vedolizumab salvage therapy in the setting of cytomegalovirus colitis for a patient with newly diagnosed very early onset inflammatory bowel disease Autoría: Alison Laxer, Morris Edelman, Julie Gallagher, Benjamin Sahn